Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.

Abstract

BACKGROUND Limited data are available describing the post-licensure safety of meningococcal vaccines, including Menveo®. We reviewed reports of adverse events (AEs) to the Vaccine Adverse Event Reporting System (VAERS) to assess safety in all age groups. METHODS VAERS is a national spontaneous vaccine safety surveillance system co-administered by the… (More)
DOI: 10.1016/j.vaccine.2017.02.030

Topics

4 Figures and Tables

Cite this paper

@article{Myers2017AdverseEF, title={Adverse events following quadrivalent meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine Adverse Event Reporting system (VAERS), 2010-2015.}, author={Tanya R. Myers and Michael M. McNeil and Carmen So-Ling Ng and Rongxia Li and Paige W Lewis and Mar{\'i}a Victoria Moreno Cano}, journal={Vaccine}, year={2017}, volume={35 14}, pages={1758-1763} }